Abiopharma

Condensed Interim Financial Statements For the Period ended 30 June 2026

INTURAI EXPANDS CRITICAL INFRASTRUCTURE SECURITY CAPABILITIES THROUGH PROPOSED DOMECOMMAND ACQUISITION AS GLOBAL COUNTER-UAS FOCUS INTENSIFIES

Immediate Report

Change of holdings of interested parties/officers - Fox-Wiesel Ltd.

Presentation for the capital market as of 30.6.26

Intel Announces Upsize and Pricing of $20 Billion Common Stock Offering

CMB.TECH fleet update

Exor and Philips Extend Long-term Relationship Agreement

Equinor ASA: Tilbakekjøp av egne aksjer – tredje transje for 2026

Equinor ASA: Share buy-back – third tranche for 2026